DISCLAIMER: FOR RESEARCH USE ONLY. The material provided is "as is", and using TOPOGRAPH is without warranties of any kind, either expressed or implied. The content provided by this resource CANNOT substitute for clinical judgement or professional oncology advice. Improper use of this resource may lead to harm.

NOTE: The haematology contents of this resource is currently under review and in the process of being updated.

Therapy-Oriented Precision Oncology Guidelines for Recommending Anti-cancer PHarmaceuticals

Database version: 20260316 (AU)

271
Gene and protein biomarkers

79
Combination biomarkers

13
Complex biomarkers

1195
Simple mutations

479
Variant groups

186
Protein expressions

184
Amplification deletions

355
Fusions and Rearrangements

5
Splice variants

7
Methylations

27
Germline mutations

45
Common cancers

82
T1

85
T2

165
T3

287
T4

10
R1

172
R2

23
Less common cancers

19
T1

12
T2

43
T3

105
T4

0
R1

21
R2

175
Rare cancers

39
T1

46
T2

124
T3

373
T4

6
R1

150
R2

© 2020-2026, Garvan Institute of Medical Research, University of Sydney, and Omico
The Kinghorn Cancer Centre, 370 Victoria Street, Darlinghurst NSW 2010, Australia.